SLC5A2 and heart failure: The beneficial effects of SGLT2 inhibitors on heart failure were also confirmed by four large randomized controlled trials (DAPA-HF, SOLOIST-WHF EMPEROR-Reduced, and EMPEROR-Preserved), in which a total of 15,684 patients participated.